These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 21569187
1. Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. Conradie F, Zorrilla C, Josipovic D, Botes M, Osiyemi O, Vandeloise E, Eley T, Child M, Bertz R, Hu W, Wirtz V, McGrath D. HIV Med; 2011 Oct; 12(9):570-9. PubMed ID: 21569187 [Abstract] [Full Text] [Related]
3. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Mirochnick M, Best BM, Stek AM, Capparelli EV, Hu C, Burchett SK, Rossi SS, Hawkins E, Basar M, Smith E, Read JS, IMPAACT 1026s Study Team. J Acquir Immune Defic Syndr; 2011 Apr 15; 56(5):412-9. PubMed ID: 21283017 [Abstract] [Full Text] [Related]
15. Ritonavir-boosted atazanavir-lopinavir combination: a pharmacokinetic interaction study of total, unbound plasma and cellular exposures. Colombo S, Buclin T, Franc C, Guignard N, Khonkarly M, Tarr PE, Rochat B, Biollaz J, Telenti A, Decosterd LA, Cavassini M. Antivir Ther; 2006 Nov 30; 11(1):53-62. PubMed ID: 16518960 [Abstract] [Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve. Bertz RJ, Persson A, Chung E, Zhu L, Zhang J, McGrath D, Grasela D. Pharmacotherapy; 2013 Mar 30; 33(3):284-94. PubMed ID: 23456732 [Abstract] [Full Text] [Related]
19. Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects. Zhu L, Persson A, Mahnke L, Eley T, Li T, Xu X, Agarwala S, Dragone J, Bertz R. J Clin Pharmacol; 2011 Mar 30; 51(3):368-77. PubMed ID: 20457590 [Abstract] [Full Text] [Related]
20. The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation. Winston A, Mallon PW, Satchell C, MacRae K, Williams KM, Schutz M, Law M, Cooper DA, Emery S. Clin Infect Dis; 2007 Jun 01; 44(11):1475-83. PubMed ID: 17479946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]